Document Detail

Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
MedLine Citation:
PMID:  19131795     Owner:  NLM     Status:  MEDLINE    
Short-term intensive chemotherapy regimens have substantially improved the prognosis of pediatric patients with Burkitt lymphoma (BL), which now has an excellent overall outcome. However, central nervous system (CNS) involvement at diagnosis remains a poor prognostic factor, and progressive or relapsed disease in the CNS is associated with even worse outcomes. We report 3 boys aged 4, 7, and 12 years treated under the French Société Française d'Oncologie Pédiatrique LMB 89/96 protocols who presented, respectively, with CNS-/bone marrow+ stage-IV BL; CNS+ stage-IV BL; and stage-I BL. Each experienced an isolated CNS relapse, which was treated with CNS-directed salvage chemotherapy. All 3 are alive after 11 years of median follow-up, indicating that this chemotherapy regimen can be curative in pediatric BL with isolated CNS relapse.
Frederic Baleydier; Corinne Pondarre; Marie-Pierre Pages; Valerie Mialou; Kamila Kebaili; Jean-Pierre Pracros; Yves Bertrand
Related Documents :
1081905 - Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumo...
6094315 - Metastatic gestational trophoblastic neoplasm. a study of two cases in unusual clinical...
3860195 - The central nervous system leukemia: a clinical and pathological study.
22971315 - Conjunctival squamous cell carcinoma following psoriasis treatment.
25431715 - Transcatheter arterial chemoembolization and chemotherapy plus sorafenib in a large hep...
7301235 - Adjunctive radiation therapy in the management of stage i cancer of the endometrium.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  30     ISSN:  1536-3678     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2009-01-09     Completed Date:  2009-02-03     Revised Date:  2011-10-06    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  972-5     Citation Subset:  IM    
Pediatric Immunology and Hematology Department, Institut d'Hématologie et Oncologie Pédiatrique, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Burkitt Lymphoma / drug therapy*,  pathology
Central Nervous System Neoplasms / drug therapy*,  pathology
Child, Preschool
Cyclophosphamide / therapeutic use
Cytarabine / therapeutic use
Magnetic Resonance Imaging
Methotrexate / therapeutic use
Neoplasm Recurrence, Local / drug therapy*,  pathology
Remission Induction
Salvage Therapy*
Treatment Outcome
Reg. No./Substance:
147-94-4/Cytarabine; 50-18-0/Cyclophosphamide; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fibrolamellar hepatocellular carcinoma in an infant and literature review.
Next Document:  Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.